The impact of a pharmacist on post-take ward round prescribing and medication appropriateness

被引:0
作者
B. Bullock
P. Donovan
C. Mitchell
J. A. Whitty
I. Coombes
机构
[1] Royal Brisbane and Women’s Hospital,Pharmacy Department
[2] University of Queensland,School of Pharmacy
[3] Gold Coast Hospital and Health Service,Medical Education Unit
[4] University of Queensland,School of Medicine
[5] Royal Brisbane and Women’s Hospital,Department Clinical Pharmacology
[6] University of East Anglia,Norwich Medical School
来源
International Journal of Clinical Pharmacy | 2019年 / 41卷
关键词
Australia; Communication; Medication safety; Prescribing; Team work; Ward round;
D O I
暂无
中图分类号
学科分类号
摘要
Background Medication communication and prescribing on the post-take ward round following patient admission to hospital can be suboptimal leading to worse patient outcomes. Objective To evaluate the impact of clinical pharmacist participation on the post-take ward round on the appropriateness of medication prescribing, medication communication, and overall patient health care outcomes. Setting Tertiary referral teaching hospital, Brisbane, Australia. Method A pre-post intervention study was undertaken that compared the addition of a senior clinical pharmacist attending the post-take ward was compared to usual wardbase pharmacist service, with no pharmacist present of the post-take ward round. We assessed the proportion of patients with an improvement in medication appropriateness from admission to discharge, using the START/STOPP checklists. Medication communication was assessed by the mean number of brief and in-depth discussions, with health care outcomes measured by comparing length of stay and 28-day readmission rates. Main outcome measures: Medication appropriateness according to the START/STOPP list, number and type of discussions with team members and length of stay and readmission rate. Results Two hundred and sixty patients were recruited (130 pre- and 130-post-intervention), across 23 and 20 post-take ward rounds, respectively. Post-intervention, there was increase in the proportion of patients who had an improvement medication appropriateness (pre-intervention 25.4%, post-intervention 36.9%; p = 0.004), the number of in-depth discussions about patients’ medication (1.9 ± 1.7 per patient pre-intervention, 2.7 ± 1.7 per patient post-, p < 0.001), and the number relating to high-risk medications (0.71 ± 1.1 per patient pre-intervention, to 1.2 ± 1.2 per patient post-, p < 0.05). Length of stay and 28-day mortality were unchanged. Conclusion Clinical pharmacist participation on the post-take ward round leads to improved medication-related communication and improved medication appropriateness but did not significantly improve health care outcomes.
引用
收藏
页码:65 / 73
页数:8
相关论文
共 71 条
[21]  
Kaboli PJ(undefined)undefined undefined undefined undefined-undefined
[22]  
Hoth AB(undefined)undefined undefined undefined undefined-undefined
[23]  
McClimon MD(undefined)undefined undefined undefined undefined-undefined
[24]  
Schnipper JL(undefined)undefined undefined undefined undefined-undefined
[25]  
Walton V(undefined)undefined undefined undefined undefined-undefined
[26]  
Hodgen A(undefined)undefined undefined undefined undefined-undefined
[27]  
Johnson J(undefined)undefined undefined undefined undefined-undefined
[28]  
Greenfield D(undefined)undefined undefined undefined undefined-undefined
[29]  
Myers B(undefined)undefined undefined undefined undefined-undefined
[30]  
Mitchell C(undefined)undefined undefined undefined undefined-undefined